Cargando…
Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery
BACKGROUND: Bariatric surgery is an effective therapy for individuals with severe obesity to achieve sustainable weight loss and to reduce comorbidities. Examining the molecular signature of subcutaneous adipose tissue (SAT) following different types of bariatric surgery may help in gaining further...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219157/ https://www.ncbi.nlm.nih.gov/pubmed/35739539 http://dx.doi.org/10.1186/s12967-022-03485-6 |
_version_ | 1784732050779013120 |
---|---|
author | Bouchard-Mercier, Annie de Toro-Martín, Juan Nadeau, Mélanie Lescelleur, Odette Lebel, Stéfane Richard, Denis Biertho, Laurent Tchernof, André Vohl, Marie-Claude |
author_facet | Bouchard-Mercier, Annie de Toro-Martín, Juan Nadeau, Mélanie Lescelleur, Odette Lebel, Stéfane Richard, Denis Biertho, Laurent Tchernof, André Vohl, Marie-Claude |
author_sort | Bouchard-Mercier, Annie |
collection | PubMed |
description | BACKGROUND: Bariatric surgery is an effective therapy for individuals with severe obesity to achieve sustainable weight loss and to reduce comorbidities. Examining the molecular signature of subcutaneous adipose tissue (SAT) following different types of bariatric surgery may help in gaining further insight into their distinct metabolic impact. RESULTS: Subjects undergoing biliopancreatic diversion with duodenal switch (BPD-DS) showed a significantly higher percentage of total weight loss than those undergoing gastric bypass or sleeve gastrectomy (RYGB + SG) (41.7 ± 4.6 vs 28.2 ± 6.8%; p = 0.00005). Individuals losing more weight were also significantly more prone to achieve both type 2 diabetes and dyslipidemia remission (OR = 0.75; 95%CI = 0.51–0.91; p = 0.03). Whole transcriptome and methylome profiling showed that bariatric surgery induced a profound molecular remodeling of SAT at 12 months postoperative, mainly through gene down-regulation and hypermethylation. The extent of changes observed was greater following BPD-DS, with 61.1% and 49.8% of up- and down-regulated genes, as well as 85.7% and 70.4% of hyper- and hypomethylated genes being exclusive to this procedure, and mostly associated with a marked decrease of immune and inflammatory responses. Weight loss was strongly associated with genes being simultaneously differentially expressed and methylated in BPD-DS, with the strongest association being observed for GPD1L (r(2) = 0.83; p = 1.4 × 10(–6)). CONCLUSIONS: Present findings point to the greater SAT molecular remodeling following BPD-DS as potentially linked with higher metabolic remission rates. These results will contribute to a better understanding of the metabolic pathways involved in the response to bariatric surgery and will eventually lead to the development of gene targets for the treatment of obesity. Trial registration ClinicalTrials.gov NCT02390973. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03485-6. |
format | Online Article Text |
id | pubmed-9219157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92191572022-06-24 Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery Bouchard-Mercier, Annie de Toro-Martín, Juan Nadeau, Mélanie Lescelleur, Odette Lebel, Stéfane Richard, Denis Biertho, Laurent Tchernof, André Vohl, Marie-Claude J Transl Med Research BACKGROUND: Bariatric surgery is an effective therapy for individuals with severe obesity to achieve sustainable weight loss and to reduce comorbidities. Examining the molecular signature of subcutaneous adipose tissue (SAT) following different types of bariatric surgery may help in gaining further insight into their distinct metabolic impact. RESULTS: Subjects undergoing biliopancreatic diversion with duodenal switch (BPD-DS) showed a significantly higher percentage of total weight loss than those undergoing gastric bypass or sleeve gastrectomy (RYGB + SG) (41.7 ± 4.6 vs 28.2 ± 6.8%; p = 0.00005). Individuals losing more weight were also significantly more prone to achieve both type 2 diabetes and dyslipidemia remission (OR = 0.75; 95%CI = 0.51–0.91; p = 0.03). Whole transcriptome and methylome profiling showed that bariatric surgery induced a profound molecular remodeling of SAT at 12 months postoperative, mainly through gene down-regulation and hypermethylation. The extent of changes observed was greater following BPD-DS, with 61.1% and 49.8% of up- and down-regulated genes, as well as 85.7% and 70.4% of hyper- and hypomethylated genes being exclusive to this procedure, and mostly associated with a marked decrease of immune and inflammatory responses. Weight loss was strongly associated with genes being simultaneously differentially expressed and methylated in BPD-DS, with the strongest association being observed for GPD1L (r(2) = 0.83; p = 1.4 × 10(–6)). CONCLUSIONS: Present findings point to the greater SAT molecular remodeling following BPD-DS as potentially linked with higher metabolic remission rates. These results will contribute to a better understanding of the metabolic pathways involved in the response to bariatric surgery and will eventually lead to the development of gene targets for the treatment of obesity. Trial registration ClinicalTrials.gov NCT02390973. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03485-6. BioMed Central 2022-06-23 /pmc/articles/PMC9219157/ /pubmed/35739539 http://dx.doi.org/10.1186/s12967-022-03485-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Bouchard-Mercier, Annie de Toro-Martín, Juan Nadeau, Mélanie Lescelleur, Odette Lebel, Stéfane Richard, Denis Biertho, Laurent Tchernof, André Vohl, Marie-Claude Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
title | Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
title_full | Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
title_fullStr | Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
title_full_unstemmed | Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
title_short | Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
title_sort | molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219157/ https://www.ncbi.nlm.nih.gov/pubmed/35739539 http://dx.doi.org/10.1186/s12967-022-03485-6 |
work_keys_str_mv | AT bouchardmercierannie molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT detoromartinjuan molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT nadeaumelanie molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT lescelleurodette molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT lebelstefane molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT richarddenis molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT biertholaurent molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT tchernofandre molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery AT vohlmarieclaude molecularremodelingofadiposetissueisassociatedwithmetabolicrecoveryafterweightlosssurgery |